XML 58 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net (Loss) Income Per Share
 9 Months Ended
Mar. 30, 2014
Earnings Per Share [Abstract]  
Net (Loss) Income Per Share
Net (Loss) Income Per Share
The following table sets forth the computation of basic and diluted net (loss) income per share: 
 
Three Months Ended
 
Nine Months Ended
 
March 30, 2014
 
March 31, 2013
 
March 30, 2014
 
March 31, 2013
 
(in thousands, except per share data)
Numerator
 
 
 
 
 
 
 
Net (loss) income
(7,199
)
 
(6,844
)
 
(14,867
)
 
(604
)
Less: Undistributed earnings allocated to participating securities
—

 
—

 
—

 
—

Undistributed earnings allocated to the Company’s common stockholders for basic net (loss) income per share
$
(7,199
)
 
$
(6,844
)
 
$
(14,867
)
 
$
(604
)
Add: Adjustment for interest expense on convertible senior notes, net of tax
—

 
—

 
—

 
—

Undistributed earnings allocated to the Company’s common stockholders for diluted net (loss) income per share
(7,199
)
 
(6,844
)
 
(14,867
)
 
(604
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Denominator for basic net (loss) income per share - weighted average shares outstanding
80,883

 
90,590

 
86,403

 
90,000

Effect of dilutive securities:
 
 
 
 
 
 
 
Dilutive options outstanding, unvested stock units, and ESPP
—

 
—

 
—

 
—

Dilutive common shares from the conversion spread of convertible senior notes
—

 
—

 
—

 
—

Dilutive common shares from forward contract of the accelerated share buyback (ASB)
—

 
—

 
—

 
—

Denominator for diluted net (loss) income per share - adjusted weighted average shares outstanding
80,883

 
90,590

 
86,403

 
90,000

Basic net (loss) income per share
$
(0.09
)
 
$
(0.08
)
 
$
(0.17
)
 
$
(0.01
)
Diluted net (loss) income per share
$
(0.09
)
 
$
(0.08
)
 
$
(0.17
)
 
$
(0.01
)
Antidilutive options and unvested stock excluded from the computations
4,665

 
5,908

 
5,353

 
6,178



The antidilutive stock options and unvested stock were excluded from the computation of diluted net income per share due to the assumed proceeds from the award’s exercise or vesting being greater than the average market price of the common shares or due to the Company incurring a net loss in the periods presented.
As the principal amount of the 2018 Notes (Note 9) will be settled in cash upon conversion, only the conversion spread relating to the 2018 Notes will be included in the calculation of diluted net income per common share. As such, the 2018 Notes will have no impact on diluted net income per common share until the price of the Company's common stock exceeds the conversion price (initially $10.30, subject to adjustments) of the 2018 Notes. When the market price of the Company's stock exceeds the conversion price, the effect of the additional shares that may be issued upon conversion of the 2018 Notes will be included in the diluted net income per common share calculation. During the three and nine month periods ended March 30, 2014, there were no anti-dilutive shares resulting from the 2018 Notes as the price of the Company's common stock did not exceed the conversion price. The forward contract component of the ASB (Note 10) was not in a dilutive position as of March 30, 2014 and accordingly, there were no antidilutive shares resulting from the ASB during the three and nine month periods ended March 30, 2014.